<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00311272</url>
  </required_header>
  <id_info>
    <org_study_id>2612-1970</org_study_id>
    <nct_id>NCT00311272</nct_id>
  </id_info>
  <brief_title>Dendritic Cell Vaccination in Patients With Advanced Colorectal Cancer</brief_title>
  <official_title>Vaccination With Autologous Dendritic Cells Pulsed With Allogenous Melanoma Lysate (MelCancerVac) for Treatment of Patients With Advanced Colorectal Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Gentofte, Copenhagen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Gentofte, Copenhagen</source>
  <brief_summary>
    <textblock>
      Dendritic cells loaded with tumor antigens induce cytotoxic T-cells which have been proved&#xD;
      capable of killing both melanoma and breast cancer cells. Melanoma and colorectal cancer&#xD;
      cells express some common antigens. Hence it is possible to use melanoma lysate to load the&#xD;
      dendritic cells with tumor antigens similar to the antigens expressed by the patients'&#xD;
      colorectal cancer cells.&#xD;
&#xD;
      The patient receives 10 vaccinations with 14 days between each. The parameters for effect are&#xD;
      changes in tumor/metastasis size measured with computed tomography (CT), decrease in serum&#xD;
      concentration of carcinoembryonic antigen (CEA), performance status measured by the World&#xD;
      Health Organization (WHO) criteria, and Quality of Life.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2004</start_date>
  <completion_date type="Actual">September 2007</completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Colorectal Neoplasms</condition>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>MelCancerVac</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Verified cancer of colon or rectum&#xD;
&#xD;
          -  No chemo- or radiation therapy in 6 weeks&#xD;
&#xD;
          -  Performance status 0, 1, or 2 (WHO criteria)&#xD;
&#xD;
          -  Adequate function of the kidneys, liver, lungs, and heart&#xD;
&#xD;
          -  Adequate function of the hematopoietic system and the coagulation system&#xD;
&#xD;
          -  Negative pregnancy test and adequate birth control for fertile women&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Uncontrolled infection&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anders Fischer, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Gentofte</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Surgical Department, University Hospital Gentofte</name>
      <address>
        <city>Hellerup</city>
        <zip>2900</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>February 2009</verification_date>
  <study_first_submitted>April 3, 2006</study_first_submitted>
  <study_first_submitted_qc>April 3, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 5, 2006</study_first_posted>
  <last_update_submitted>February 17, 2009</last_update_submitted>
  <last_update_submitted_qc>February 17, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 18, 2009</last_update_posted>
  <keyword>dendritic cells</keyword>
  <keyword>antigens, neoplasm</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colorectal Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

